TGFB1 and Hepatic fibrosis: Further, therapeutic administration of the αV integrin-specific-RGD peptidomimetic antagonist CWHM 12 also reduced pre-existing hepatic fibrosis, most probably again due to lowered TGFβ1 activation [97].